Detalhe da pesquisa
1.
Neoantigen Cancer Vaccines and Different Immune Checkpoint Therapies Each Utilize Both Converging and Distinct Mechanisms that in Combination Enable Synergistic Therapeutic Efficacy.
bioRxiv
; 2024 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38187708
2.
BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy.
Cancer Immunol Res
; 10(5): 597-611, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35181783